Clinical, endocrine, and metabolic effects of acarbose, a α-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome
To access this article, please choose from the options below
PII: S0015-0282(07)02963-9
doi:10.1016/j.fertnstert.2007.07.1326
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

